These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19664602)

  • 1. Targeting of the protein interaction site between FAK and IGF-1R.
    Zheng D; Kurenova E; Ucar D; Golubovskaya V; Magis A; Ostrov D; Cance WG; Hochwald SN
    Biochem Biophys Res Commun; 2009 Oct; 388(2):301-5. PubMed ID: 19664602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells.
    Liu W; Bloom DA; Cance WG; Kurenova EV; Golubovskaya VM; Hochwald SN
    Carcinogenesis; 2008 Jun; 29(6):1096-107. PubMed ID: 18263593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth.
    Ucar DA; Kurenova E; Garrett TJ; Cance WG; Nyberg C; Cox A; Massoll N; Ostrov DA; Lawrence N; Sebti SM; Zajac-Kaye M; Hochwald SN
    Cell Cycle; 2012 Sep; 11(17):3250-9. PubMed ID: 22894899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells.
    Rigiracciolo DC; Nohata N; Lappano R; Cirillo F; Talia M; Scordamaglia D; Gutkind JS; Maggiolini M
    Cells; 2020 Apr; 9(4):. PubMed ID: 32325700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting the interaction of cMET and IGF-1R with FAK effectively reduces growth of pancreatic cancer cells in vitro and in vivo.
    Ucar DA; Magis AT; He DH; Lawrence NJ; Sebti SM; Kurenova E; Zajac-Kaye M; Zhang J; Hochwald SN
    Anticancer Agents Med Chem; 2013 May; 13(4):595-602. PubMed ID: 23272972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal adhesion kinase (FAK) activates and stabilizes IGF-1 receptor.
    Andersson S; D'Arcy P; Larsson O; Sehat B
    Biochem Biophys Res Commun; 2009 Sep; 387(1):36-41. PubMed ID: 19545541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel small molecule inhibitor of FAK and IGF-1R protein interactions decreases growth of human esophageal carcinoma.
    Ucar DA; Cox A; He DH; Ostrov DA; Kurenova E; Hochwald SN
    Anticancer Agents Med Chem; 2011 Sep; 11(7):629-37. PubMed ID: 21707510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precise mapping of an IGF-I-binding site on the IGF-1R.
    Keyhanfar M; Booker GW; Whittaker J; Wallace JC; Forbes BE
    Biochem J; 2007 Jan; 401(1):269-77. PubMed ID: 16981855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1.
    Sanabria-Figueroa E; Donnelly SM; Foy KC; Buss MC; Castellino RC; Paplomata E; Taliaferro-Smith L; Kaumaya PT; Nahta R
    Mol Pharmacol; 2015 Feb; 87(2):150-61. PubMed ID: 25391374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific activation of insulin-like growth factor-1 receptor by ginsenoside Rg5 promotes angiogenesis and vasorelaxation.
    Cho YL; Hur SM; Kim JY; Kim JH; Lee DK; Choe J; Won MH; Ha KS; Jeoung D; Han S; Ryoo S; Lee H; Min JK; Kwon YG; Kim DH; Kim YM
    J Biol Chem; 2015 Jan; 290(1):467-77. PubMed ID: 25391655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone targets the ATP-binding site of FAK, binds the FAK kinase domain and decreases FAK, Pyk-2, c-Src, and IGF-1R in vitro kinase activities.
    Golubovskaya VM; Ho B; Zheng M; Magis A; Ostrov D; Cance WG
    Anticancer Agents Med Chem; 2013 May; 13(4):546-54. PubMed ID: 22292772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel strategy to inhibit FAK and IGF-1R decreases growth of pancreatic cancer xenografts.
    Zheng D; Golubovskaya V; Kurenova E; Wood C; Massoll NA; Ostrov D; Cance WG; Hochwald SN
    Mol Carcinog; 2010 Feb; 49(2):200-9. PubMed ID: 19885860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.
    Taliaferro-Smith L; Oberlick E; Liu T; McGlothen T; Alcaide T; Tobin R; Donnelly S; Commander R; Kline E; Nagaraju GP; Havel L; Marcus A; Nahta R; O'Regan R
    Oncotarget; 2015 Mar; 6(7):4757-72. PubMed ID: 25749031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II.
    Alvino CL; McNeil KA; Ong SC; Delaine C; Booker GW; Wallace JC; Whittaker J; Forbes BE
    J Biol Chem; 2009 Mar; 284(12):7656-64. PubMed ID: 19139090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a High-Throughput Fluorescence Polarization Assay to Detect Inhibitors of the FAK-Paxillin Interaction.
    Marlowe T; Alvarado C; Rivera A; Lenzo F; Nott R; Bondugji D; Montoya J; Hurley A; Kaplan M; Capaldi A; Cance W
    SLAS Discov; 2020 Jan; 25(1):21-32. PubMed ID: 31513463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone I inhibits vascular smooth muscle cell proliferation by targeting insulin-like growth factor-1 receptor/phosphatidylinositol-3-kinase signaling pathway.
    Wu YT; Bi YM; Tan ZB; Xie LP; Xu HL; Fan HJ; Chen HM; Li J; Liu B; Zhou YC
    Eur J Pharmacol; 2019 Jun; 853():93-102. PubMed ID: 30878387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models.
    Fukami S; Tomioka D; Murakami Y; Honda T; Hatakeyama S
    BMC Res Notes; 2019 Jun; 12(1):347. PubMed ID: 31215459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change.
    Whitten AE; Smith BJ; Menting JG; Margetts MB; McKern NM; Lovrecz GO; Adams TE; Richards K; Bentley JD; Trewhella J; Ward CW; Lawrence MC
    J Mol Biol; 2009 Dec; 394(5):878-92. PubMed ID: 19835884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane.
    Song RX; Barnes CJ; Zhang Z; Bao Y; Kumar R; Santen RJ
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2076-81. PubMed ID: 14764897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
    Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW
    Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.